Skip to main content
. 2011 May 5;111(1):295–302. doi: 10.1152/japplphysiol.00629.2010

Table 2.

Summary statistics for each patient's CBF

Group Case Average Standard Deviation Variation Coefficient, % Median Minimum Maximum
A 1 3.6 4.0 112 2 2 15
A 2 2.3 0.5 21 2 2 3
A 3 2.8 1.2 44 2 2 5
A 4 5.7 3.2 57 5 2 13
A 5 5.1 4.3 84 3 2 13
A 6 3.2 1.0 32 3 2 5
A 7 2.2 0.4 19 2 2 3
A 8 2.3 0.5 21 2 2 3
A 9 3.6 1.7 48 3 2 8
A 10 7.4 2.2 29 7 3 12
A 11 7.2 4.4 61 8 2 18
B 1 11.2 7.1 63 10 5 30
B 2 10.8 8.2 76 8 5 30
B 3 13.1 9.0 69 10 7 30
B 4 10.9 7.1 66 10 5 30
B 5 18.4 10.1 55 12 8 30
B 6 15.1 10.4 69 9 7 30
B 7 9.7 2.2 22 10 7 13
B 8 19.1 6.9 36 19 8 30
B 9 14.2 4.3 30 14 8 22
B 10 17.3 10.0 58 10 8 30
C 1 9.8 7.3 74 8 5 30
C 2 15.5 8.9 57 13 2 30
C 3 7.4 2.4 32 8 2 10
C 4 6.5 2.3 36 6 3 10
C 5 8.6 3.9 45 7 3 17
C 6 7.6 4.9 65 5 3 20
C 7 12.2 9.8 80 9 2 30
C 8 6.3 2.4 38 6 3 12
C 9 6.0 2.3 38 5 2 10
C 10 6.4 5.9 92 3 2 18
C 11 10.7 3.9 36 10 2 15
C 12 10.8 2.2 20 10 8 15
C 13 15.8 5.5 35 14 10 25

Group A, patients with altered cilia ultrastructure [primary ciliary dyskinesia (PCD) patients]; group B, control group; group C, patients with normal cilia ultrastructure.